![Christine Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christine Murray
Algemeen Adviseur bij
CYTOKINETICS, INCORPORATED
Profiel
Christine Murray is Senior VP-Global Regulatory Affairs at Cytokinetics, Inc. since 2023.
Former roles include Independent Director at Eiger BioPharmaceuticals, Inc. from 2019 to 2024; Vice President-Regulatory Affairs at Achaogen, Inc. from 2011 to 2015; Vice President-Global Regulatory Affairs at Horizon Pharmaceutical LLC from 2015 to 2017; Vice President-Regulatory Affairs at Raptor Pharmaceuticals, Inc. from 2015 to 2017; and Senior Vice President-Global Regulatory Affairs at Ultragenyx Pharmaceutical, Inc. from 2018 to 2021.
Education includes undergraduate studies at The University of Liverpool and graduate studies at Newcastle University.
Actieve functies van Christine Murray
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Algemeen Adviseur | 01-04-2023 |
Eerdere bekende functies van Christine Murray
| Bedrijven | Functie | Einde |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Directeur/Bestuurslid | 15-03-2024 |
| ULTRAGENYX PHARMACEUTICAL INC. | Algemeen Adviseur | 01-09-2021 |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Corporate Officer/Principal | 01-02-2017 |
| RAPTOR PHARMACEUTICAL CORP | Algemeen Adviseur | 01-01-2017 |
| ACHAOGEN | Algemeen Adviseur | 02-01-2015 |
Opleiding van Christine Murray
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
54
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newcastle University
 Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets life-altering therapeutics | Health Technology |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
